Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin L Ebert

Showing results (261-270 of 339) with videos related to

Pageof 34
Sort By:
Blood|June 20, 2023
Epichaperome inhibition targets TP53-mutant AML and AML stem/progenitor cellsBing Z Carter, Po Yee Mak, Muharrem Muftuoglu, et al.
Science Translational Medicine|October 22, 2020
Calmodulin inhibitors improve erythropoiesis in Diamond-Blackfan anemiaAlison M Taylor, Elizabeth R Macari, Iris T Chan, et al.
Cancer Discovery|June 15, 2018
CDK6 Antagonizes p53-Induced Responses during TumorigenesisFlorian Bellutti, Anca-Sarmiza Tigan, Sofie Nebenfuehr, et al.
Cancer Discovery|August 25, 2021
Systematic Profiling of <i>DNMT3A</i> Variants Reveals Protein Instability Mediated by the DCAF8 E3 Ubiquitin Ligase AdaptorYung-Hsin Huang, Chun-Wei Chen, Venkatasubramaniam Sundaramurthy, et al.
Cell Chemical Biology|February 11, 2026
Metabolic control of innate immune activation in TET2-mutant clonal hematopoiesisPeter Geon Kim, Christopher B Hergott, Aidan P Miller, et al.
Nature|June 5, 2020
The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin KMikołaj Słabicki, Zuzanna Kozicka, Georg Petzold, et al.
Blood|June 17, 2022
TET2-mutant clonal hematopoiesis and risk of goutMridul Agrawal, Abhishek Niroula, Pierre Cunin, et al.
Science Translational Medicine|February 10, 2017
Drug discovery for Diamond-Blackfan anemia using reprogrammed hematopoietic progenitorsSergei Doulatov, Linda T Vo, Elizabeth R Macari, et al.
Blood|January 29, 2021
Modeling and targeting of erythroleukemia by hematopoietic genome editingIlaria Iacobucci, Chunxu Qu, Elena Varotto, et al.
Blood|May 8, 2026
Ikaros degradation by mezigdomide reduces T-cell dysfunction and improves the efficacy of antimyeloma T-cell therapiesLucia Y Chen, Adolfo Aleman, Marta Larrayoz, et al.
Pageof 34

Showing results (261-270 of 339) with videos related to

Sort By:
Pageof 34
Blood|June 20, 2023
Epichaperome inhibition targets TP53-mutant AML and AML stem/progenitor cellsBing Z Carter, Po Yee Mak, Muharrem Muftuoglu, et al.
Science Translational Medicine|October 22, 2020
Calmodulin inhibitors improve erythropoiesis in Diamond-Blackfan anemiaAlison M Taylor, Elizabeth R Macari, Iris T Chan, et al.
Cancer Discovery|June 15, 2018
CDK6 Antagonizes p53-Induced Responses during TumorigenesisFlorian Bellutti, Anca-Sarmiza Tigan, Sofie Nebenfuehr, et al.
Cancer Discovery|August 25, 2021
Systematic Profiling of <i>DNMT3A</i> Variants Reveals Protein Instability Mediated by the DCAF8 E3 Ubiquitin Ligase AdaptorYung-Hsin Huang, Chun-Wei Chen, Venkatasubramaniam Sundaramurthy, et al.
Cell Chemical Biology|February 11, 2026
Metabolic control of innate immune activation in TET2-mutant clonal hematopoiesisPeter Geon Kim, Christopher B Hergott, Aidan P Miller, et al.
Nature|June 5, 2020
The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin KMikołaj Słabicki, Zuzanna Kozicka, Georg Petzold, et al.
Blood|June 17, 2022
TET2-mutant clonal hematopoiesis and risk of goutMridul Agrawal, Abhishek Niroula, Pierre Cunin, et al.
Science Translational Medicine|February 10, 2017
Drug discovery for Diamond-Blackfan anemia using reprogrammed hematopoietic progenitorsSergei Doulatov, Linda T Vo, Elizabeth R Macari, et al.
Blood|January 29, 2021
Modeling and targeting of erythroleukemia by hematopoietic genome editingIlaria Iacobucci, Chunxu Qu, Elena Varotto, et al.
Blood|May 8, 2026
Ikaros degradation by mezigdomide reduces T-cell dysfunction and improves the efficacy of antimyeloma T-cell therapiesLucia Y Chen, Adolfo Aleman, Marta Larrayoz, et al.
Pageof 34